Exparel 266 MG/20 ML vial 20ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJUV6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,374
Award facts
- Contract value 100% obligated
- $15,373.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,373.56 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 266 mg/20 mL vials of EXPAREL, a specialty surgical anesthetic product. The delivery order, issued on December 17, 2025, with an ultimate completion date of January 9, 2026, carries no set-aside designation, indicating the award was made through open competition. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499.999 billion ceiling value through December 31, 2036.
The PPV-G GEN V represents a critical component of the Department of Defense's pharmaceutical supply chain strategy, designed to provide comprehensive pharmaceutical and medical consumables support to military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across numerous delivery orders demonstrates its capability to supply specialized pharmaceutical products including oncology treatments, biologics, vaccines, and surgical supplies to federal military medical systems. As a prime vendor under this $30.3 billion acquisition strategy, the company serves as a key regional pharmaceutical supplier supporting the recurring medical supply needs of DoD healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FJUV6?
SPE2DR26FJUV6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26FJUV6 worth?
The government has obligated $15,374 on SPE2DR26FJUV6.
Is contract SPE2DR26FJUV6 an order under another contract?
Yes. SPE2DR26FJUV6 is a delivery order under SPE2DR25D9329, an indefinite delivery contract.
Was contract SPE2DR26FJUV6 competed?
The extent of competition for SPE2DR26FJUV6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award